Abstract
In spite of the reports on the therapy with pyridoxine, aldose reductase inhibitors,2–4 and myoinositol, 5,6; at present no specific treatment is available for diabetic peripheral neuropathy, the most frequent long-term complication of diabetes mellitus.
The trial has been carried out in collaboration with: A. Tiengo, P. Negrin (Padova), G. Pozza, N. Canal, G. C. Comi (Milano), G. F. Lenti, G. F. Pagano, L. Bergamini, W. Troni (Torino), F. Frigato, C. Ravenna, C. Mezzina (Mestre-Venezia), D. Massari, R. Gallato, M. Massarotti, R. Matano (Abano Terme), F. Grigoletto (Padova), H. Davis (Rochester), and M. Klein (New Jersey).
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
E. R. Levin, T. A. Hanscom, M. Fisher, W. A. Laustad, A. Lui, A. Ryan, D. Glokner, and S. R. Levin, The influence of pyridoxine in diabetic peripheral neuropathy, Diabetes Care 4:606 (1981).
K. H. Gabbay, N. Spack, S. Loo, J. L. Hirsh, and A. A. Ackil, Aldose reductase inhibition: studies with alrestatin, Metabolism 28(Suppl):471 (1979).
A. Culebras, J. Alio, and J. L. Herrera, Effect of aldose reductase inhibitor on diabetic peripheral neuropathy, Arch. Neurol. 38:133 (1981).
R. G. Judzerwitsch, J. B. Jaspan, K. S. Polonsky et al., Aldose reductase inhibition improves nerve conduction velocity in diabetic patients, New Engl. J. Med. 308:119 (1983).
D. A. Greene, P. V. De Jesus, and A. I. Winegrad, Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes, J. Clin. Invest. 55:1326 (1975).
R. S. Clements, Jr., B. Vaurganti, T. Kuba, S. J. Oh, and B. Darnell, Dietary myoinositol intake and peripheral nerve function in diabetic neuropathy, Metabolism 28:477 (1979).
A. Mingione, M. Monteleone, G. Paruzzi, O. Soragni, G. Cristiani, C. Moretti, W. Mega, and F. Scanabissi, Research in the cerebral gangliosides in neurolyses of the upper limb, Clin. Neurophysiol. 19:353 (1979).
S. Bassi, M. G. Albizzati, and L. Frattola, Electromyographic study of diabetic and alcoholic Polyneuropathic patients treated with gangliosides, Muscle & Nerve 5:351 (1982).
B. Ceccarelli, F. Aporti, and M. Finesso, Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation, in: “Ganglioside Function,” G. Porcellati, B. Ceccarelli, and G. Tettamanti, eds., Plenum Press, New York and London (1976).
A. Gorio, G. Carmignoto, L. Facci, and M. Finesso, Motor nerve sprouting induced by gangliosides treatment. Possible indications for gangliosides on neuronal growth, Brain Res. 197:236 (1980).
A. Gorio, G. Carmignoto, and G. Ferrari, Axon sprouting stimulated by gangliosides. A new model for elongation and sprouting, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport and A. Gorio, eds., Raven Press, New York (1981).
F. Norido, R. Canella, and F. Aporti, Acceleration of nerve regeneration by gangliosides estimated by the somatosensory evoked potentials, Experientia (Basel) 37:301 (1981).
A. Gorio, P. Marini, and R. Zanoni, Muscle reinnervation III. Motoneuron sprouting capacity, enhancement by exogenous gangliosides, Neuroscience 8:417 (1983).
A. Gorio, F. Aporti, and F. Norido, Ganglioside treatment in experimental diabetic neuropathy, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport and A. Gorio, eds., Raven Press, New York (1981).
A. Gorio, G. Carmignoto, G. Ferrari, F. Norido, M. G. Nunzi, R. Rubini, and R. Zanoni, Pharmacological aspects of experimental peripheral neuropathy, in: “International Conference on Peripheral Neuropathies,” S. Refsum, C. L. Bolis, and Portera-Sanchez, eds., Excerpta Medica, Amsterdam, Oxford-Princeton (1982).
F. Norido, R. Canella, and A. Gorio, Ganglioside treatment of neuropathy in diabetic mice, Muscle & Nerve 5:107 (1982).
G. Pozza, V. Saibene, G. Comi, and N. Canal, The effect of ganglioside administration in human diabetic peripheral neuropathy, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport and A. Gorio, eds., Raven Press, New York (1981).
J. W. Daly, The effect of gangliosides on activity of adenylate cyclase and phosphodiesterase from rat cerebral cortex, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport and A. Gorio, eds., Raven Press, New York (1981).
A. Leon, L. Facci, G. Toffano, S. Sonnino, and G. Tettamanti, Activation of (Na+K+)ATPase by nanomolar concentrations of GM1 ganglioside, J. Neurochem. 37:350 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Fedele, D., Crepaldi, G., Battistin, L. (1984). Multicentre Trial on Gangliosides in Diabetic Peripheral Neuropathy. In: Ledeen, R.W., Yu, R.K., Rapport, M.M., Suzuki, K. (eds) Ganglioside Structure, Function, and Biomedical Potential. Advances in Experimental Medicine and Biology, vol 174. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1200-0_51
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1200-0_51
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1202-4
Online ISBN: 978-1-4684-1200-0
eBook Packages: Springer Book Archive